Ebpay生命医药出版社

Ebpay生命

102445

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

黄芩苷在椎间盘退变中的治疗潜力揭示:整合的转录组分析及单细胞分析,并顺利获得实验验证其对PANoptosis的抑制作用

 

Authors Wang X, Gao S , Zhou D, Cai W, Lv J, Wei Z, Song C, Shan X, Liu Z 

Received 13 February 2025

Accepted for publication 16 May 2025

Published 30 May 2025 Volume 2025:18 Pages 6963—6981

DOI http://doi.org/10.2147/JIR.S519179

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Ning Quan

Xiaoqiang Wang,1,2,* Silong Gao,2,* Daqian Zhou,2 Weiye Cai,3 Jiale Lv,2 Zhangchao Wei,2 Chao Song,2 Xubin Shan,4 Zongchao Liu1,2 

1Luzhou Longmatan District People’s Hospital, Luzhou, Sichuan Province, People’s Republic of China; 2Department of Orthopedics and Traumatology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, People’s Republic of China; 3Department of Orthopedics and Traumatology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, 215009, People’s Republic of China; 4Gaoxian Traditional Chinese Medicine Hospital, Yibin, Sichuan Provience, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Zongchao Liu, Luzhou Longmatan District People’s Hospital, No. 2 Guanyinbao Road, Shidong Town, Longmatan District, Luzhou, Sichuan, 646000, People’s Republic of China, Email lzcxnykdx@swmu.edu.cn

Background: Programmed cell death (PCD), including pyroptosis, apoptosis, and necroptosis, plays a critical role in the pathogenesis of intervertebral disc degeneration (IVDD). PANoptosis, a recently identified form of PCD integrating pyroptosis, apoptosis, and necroptosis, may represent a more comprehensive target for therapeutic intervention in IVDD.
Objective: To explore the role of PANoptosis in IVDD and investigate the therapeutic potential and underlying mechanism of baicalin in regulating PANoptosis to alleviate disc degeneration.
Methods: We performed integrative analyses of bulk transcriptomic datasets (GSE167199, GSE245147, GSE266883) and a single-cell RNA-seq dataset (GSE244889) to identify PANoptosis-related genes involved in IVDD. The expression and function of key genes were validated using clinical samples, an IL-1β-induced NPC degeneration model in vitro, and a puncture-induced rat IVDD model in vivo treated with baicalin.
Results: Five core PANoptosis-related genes (FOS, CASP1, H1-2, BCL2L11, and H2AC6) were significantly upregulated in degenerated discs. Baicalin treatment effectively downregulated these genes at both mRNA and protein levels. Moreover, baicalin alleviated IL-1β-induced cell death in NPCs and improved histological features in the rat IVDD model.
Conclusion: Our findings reveal a critical role of PANoptosis in IVDD progression and demonstrate that baicalin alleviates disc degeneration by inhibiting PANoptosis. This study provides novel insights into PANoptosis as a promising therapeutic target for IVDD.

Keywords: intervertebral disc degeneration, Baicalin, PANoptosis, bioinformatics, single-cell

Download Article[PDF]